Nature Search

A hybrid GAN-based deep learning framework for thermogram-based breast cancer detection

Preethi Veerlapalli
Sushama Rani Dutta
ResearchOpen Access04 Jun 2025
Scientific Reports

Volume: 15, P: 1-33
A HER3-targeting antibody–drug conjugate for leptomeningeal metastasis

The phase 2 TUXEDO-3 trial identifies the HER3-targeting antibody–drug conjugate patritumab deruxtecan as a promising new therapeutic option for patients with leptomeningeal metastasis from solid tumors.

Carey K. Anders
Rani Bansal
Amanda E. D. Van Swearingen
News & Views31 Jul 2025
Nature Medicine

Volume: 31, P: 2494-2495
Blood-based tumor mutational burden impacts clinical outcomes of immune checkpoint inhibitor treated breast and prostate cancers

Barnett et al. explore the role of blood-based tumor mutation burden in predicting outcomes to immune checkpoint inhibitors in patients with advanced breast or prostate cancers. They find immune checkpoint inhibitors were not offered based on blood-based tumor mutation burden, and this did not predict response.

Reagan M. Barnett
Albert Jang
Pedro Barata
ResearchOpen Access02 Dec 2024
Communications Medicine

Volume: 4, P: 1-7
A comprehensive evaluation of de novo metastatic breast cancer trends by subtype from the Dallas Metastatic Cancer Study

Chang, Cao et al. examine local trends associated with the diagnosis and treatment of de novo metastatic breast cancer. Findings show that black race, hypertension, diabetes, as well as the presence of visceral metastases are associated with a worse prognosis.

Hannah L. Chang
Meng Cao
Isaac S. Chan
ResearchOpen Access05 Aug 2025
Communications Medicine

Volume: 5, P: 1-7

Quick links

Search

Filter By:

A hybrid GAN-based deep learning framework for thermogram-based breast cancer detection

A HER3-targeting antibody–drug conjugate for leptomeningeal metastasis

Blood-based tumor mutational burden impacts clinical outcomes of immune checkpoint inhibitor treated breast and prostate cancers

A comprehensive evaluation of de novo metastatic breast cancer trends by subtype from the Dallas Metastatic Cancer Study

Search

Quick links